Skip to main content
Michael Risner

Michael Risner

Assistant Professor at Oakland University William Beaumont School of Medicine's Eye Research Center, researching glaucoma pathophysiology and retinal neurobiology.

Sep 15, 2026

12:16
And can you speak to the, the lifetime of research? Because I think a lot of people in our community are really eager to find cures, severe retinal diseases, but how long can it actually take?
12:30
Well, I think it-- that depends really about how much funding there, there is for cer-certain disease or...
12:39
For example, we just, what was it? Six years ago, we went through COVID, right? A development for a vaccine for this virus occurred relatively rapidly because there was a huge push from the government and other foundations to, um, bring that therapy, that treatment to the fore.
13:03
And also, there's the, uh, the workforce behind those, uh, therapies, and the workforce has to be there.
13:11
And for the workforce to be there, there has to be continual funding to generate those new master's degree students, those new PhDs who are working for, uh, to treat human diseases.
13:24
So I think, uh, funding from the government and the, and other agencies such as the PRRF are essential in the development of the workforce and of course the, this, the funding for doing the actual work.
13:38
So how long does it take? Well, like I said, it depends upon the interest and as much interest as you can, as you can gather up, well, that further supports the, um, how long it's going to take to get a treatment for a particular disease.
15:18
What got you into this line of work, of all things to study? Why were you attracted to this, and how does it feel personal- on a personal level to be in the lab working on these, uh, these types of studies?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.